Enrolling By Invitation OBSERVATIONAL NCT06058676

Prediction of Hyperperfusion After Carotid Stenting by Multi-parameter Characteristics Based on Cerebral Autoregulation (HACASS)

A Controlled Clinical Study of Prediction of Cerebral Hyperperfusion Syndrome After Carotid Artery Stenting by Using Multi-parameter Characteristics Based on Cerebral Autoregulation

Sponsor: Xuanwu Hospital, Beijing

Conditions Carotid Artery Stent Cerebral Artery Stenosis Dynamic Cerebral Autoregulation

Interventions carotid artery stenting

Updated 3 times since 2023 Last updated: Sep 21, 2023 Started: Sep 1, 2023 Primary completion: Dec 31, 2025 Completion: Sep 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06058676, this observational or N/A phase trial focuses on Carotid Artery Stent and Cerebral Artery Stenosis and remains ongoing. Sponsored by Xuanwu Hospital, Beijing, it has been updated 3 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Enrolling By Invitation
Jul 2024 — Sep 2024 [monthly]

Enrolling By Invitation
Oct 2023 — Jul 2024 [monthly]

Enrolling By Invitation

First recorded

Sep 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xuanwu Hospital, Beijing

Data source: Xuanwu Hospital, Beijing

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China